The conference will explore new technologies and advances in the field of on-body devices which can be used for the administration of viscous and large molecule drugs. It will discuss the relevance of connectivity to the ‘internet of things,’ and ways to enhance the interface between the product and the user. The global wearable devices market size is expected to reach a value of $12.1 billion by 2021.
